Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Ishiguro T"" wg kryterium: Autor


Tytuł :
[A Case of Advanced Recurrent Colorectal Cancer with Complete Response to Pembrolizumab Chemotherapy].
Autorzy :
Ishiguro T; Dept. of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University.
Ishikawa H
Muta Y
Ito T
Chikatani K
Chika N
Amano K
Hatano S
Suzuki O
Mori Y
Kumagai Y
Ishibashi K
Mochiki E
Ishida H
Pokaż więcej
Źródło :
Gan to kagaku ryoho. Cancer & chemotherapy [Gan To Kagaku Ryoho] 2020 Dec; Vol. 47 (13), pp. 2299-2301.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols*/therapeutic use
Sigmoid Neoplasms*/drug therapy
Sigmoid Neoplasms*/surgery
Aged ; Antibodies, Monoclonal, Humanized/therapeutic use ; Humans ; Male ; Neoplasm Recurrence, Local/drug therapy
Czasopismo naukowe
Tytuł :
A randomized phase 3 study of maintenance therapy with S-1 plus best supportive care versus best supportive care after induction therapy with carboplatin plus S-1 for advanced or relapsed squamous cell carcinoma of the lung (WJOG7512L).
Autorzy :
Tanaka K; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan.
Morita S; Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Ando M; Data Coordinating Center, Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
Yokoyama T; Department of Respiratory Medicine, Kyorin University School of Medicine, Tokyo, Japan.
Nakamura A; Department of Pulmonary Medicine, Sendai Kousei Hospital, Sendai, Japan.
Yoshioka H; Department of Thoracic Oncology, Kansai Medical University, Hirakata, Japan.
Ishiguro T; Division of Respiratory Medicine and Oncology, Gifu Municipal Hospital, Gifu, Japan.
Miura S; Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan.
Toyozawa R; Department of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Oguri T; Department of Education and Research Center for Community Medicine, Nagoya City University Graduate School of Medical Sciences, Aichi, Japan.
Daga H; Department of Clinical Oncology, Osaka City General Hospital, Osaka, Japan.
Ko R; Department of Respiratory Medicine, Juntendo University School of Medicine, Tokyo, Japan.
Bessho A; Department of Respiratory Medicine, Japanese Red Cross Okayama Hospital, Okayama, Japan.
Tachihara M; Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Iwamoto Y; Department of Respiratory Medicine, Hiroshima City Hospital, Hiroshima, Japan.
Hirano K; Department of Respiratory Medicine, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.
Nakanishi Y; Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Nakagawa K; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan.
Yamamoto N; Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.
Okamoto I; Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Pokaż więcej
Źródło :
Cancer [Cancer] 2020 Aug 15; Vol. 126 (16), pp. 3648-3656. Date of Electronic Publication: 2020 Jun 02.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Carcinoma, Squamous Cell/*drug therapy
Lung/*drug effects
Lung Neoplasms/*drug therapy
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Carboplatin/administration & dosage ; Carboplatin/adverse effects ; Carcinoma, Squamous Cell/epidemiology ; Carcinoma, Squamous Cell/pathology ; Cisplatin/administration & dosage ; Cisplatin/adverse effects ; Drug Combinations ; Humans ; Induction Chemotherapy ; Lung/pathology ; Lung Neoplasms/epidemiology ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Oxonic Acid/administration & dosage ; Oxonic Acid/adverse effects ; Pemetrexed/administration & dosage ; Pemetrexed/adverse effects ; Progression-Free Survival ; Proportional Hazards Models ; Tegafur/administration & dosage ; Tegafur/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Variants of carboxylesterase 1 have no impact on capecitabine pharmacokinetics and toxicity in capecitabine plus oxaliplatin treated-colorectal cancer patients.
Autorzy :
Matsumoto N; Division of Cancer Genome and Pharmacotherapy, Department of Clinical Pharmacy, Showa University School of Pharmacy, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.
Kubota Y; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.
Ishida H; Division of Medical Oncology, Showa University Koto Toyosu Hospital, Koto-ku, Tokyo, 1358577, Japan.
Sekido M; Division of Cancer Cell Biology, Department of Pharmaceutical Science, Showa University School of Pharmacy, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.
Ohkuma R; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.
Ishiguro T; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.
Hirasawa Y; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.
Ariizumi H; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.
Tsunoda T; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.
Ikusue T; Division of Medical Oncology, Showa University Koto Toyosu Hospital, Koto-ku, Tokyo, 1358577, Japan.
Kobayashi K; Division of Medical Oncology, Showa University Koto Toyosu Hospital, Koto-ku, Tokyo, 1358577, Japan.
Hisamatsu A; Division of Medical Oncology, Showa University Koto Toyosu Hospital, Koto-ku, Tokyo, 1358577, Japan.
Toshima H; Division of Medical Oncology, Showa University Koto Toyosu Hospital, Koto-ku, Tokyo, 1358577, Japan.
Shimada K; Division of Medical Oncology, Showa University Koto Toyosu Hospital, Koto-ku, Tokyo, 1358577, Japan.
Fujita KI; Division of Cancer Genome and Pharmacotherapy, Department of Clinical Pharmacy, Showa University School of Pharmacy, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan. .
Pokaż więcej
Źródło :
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2020 Jun; Vol. 85 (6), pp. 1119-1128. Date of Electronic Publication: 2020 May 26.
Typ publikacji :
Journal Article
MeSH Terms :
Polymorphism, Single Nucleotide*
Antineoplastic Combined Chemotherapy Protocols/*adverse effects
Antineoplastic Combined Chemotherapy Protocols/*pharmacokinetics
Carboxylic Ester Hydrolases/*genetics
Colorectal Neoplasms/*drug therapy
Drug-Related Side Effects and Adverse Reactions/*epidemiology
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Biomarkers, Tumor/genetics ; Capecitabine/administration & dosage ; Colorectal Neoplasms/enzymology ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/pathology ; Drug-Related Side Effects and Adverse Reactions/genetics ; Drug-Related Side Effects and Adverse Reactions/pathology ; Female ; Follow-Up Studies ; Gene Expression Regulation, Enzymologic ; Gene Expression Regulation, Neoplastic ; Humans ; Japan/epidemiology ; Male ; Middle Aged ; Oxaliplatin/administration & dosage ; Prognosis ; Prospective Studies ; Response Evaluation Criteria in Solid Tumors ; Tissue Distribution
Czasopismo naukowe
Tytuł :
Differences in disease status between patients with progression after first-line chemotherapy versus early relapse after adjuvant chemotherapy who undergo second-line chemotherapy for gastric cancer: Exploratory analysis of the randomized phase III TRICS trial.
Autorzy :
Nishikawa K; Department of Surgery, National Hospital Organization Osaka National Hospital, 2-1-14, Houenzaka, Chuo-ku, Osaka, 540-0006 Japan. Electronic address: .
Murotani K; Biostatistics Center, Graduate School of Medicine, Kurume University, 67 Asahi-machi, Kurume, Fukuoka, 830-0011, Japan. Electronic address: .
Fujitani K; Department of Surgery, Osaka General Medical Center, 3-1-56, Bandaihigashi, Sumiyoshi-ku, Osaka, 558-0056 Japan. Electronic address: .
Inagaki H; Department of Surgery, Inagaki Clinic, 1-2-9, Nenohanacho, Owariasahi, 488-0002 Japan. Electronic address: .
Akamaru Y; Department of Surgery, Ikeda Municipal Hospital, 3-1-18, Jonan, Ikeda, 563-8510 Japan. Electronic address: .
Tokunaga S; Department of Medical Oncology, Osaka City General Hospital, 2-13-22, Miyakojimahondori, Miyakojima-ku, Osaka, 534-0021 Japan. Electronic address: t.
Takagi M; Department of Surgery, Shizuoka General Hospital, 4-27-1, Kitaando, Aoi-ku, Shizuoka, 420-0881 Japan. Electronic address: .
Tamura S; Department of Surgery, Yao Municipal Hospital, 1-3-1, Ryugecho, Yao, 581-0069 Japan. Electronic address: .
Sugimoto N; Department of Medical Oncology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-ku, Osaka, 541-8567 Japan. Electronic address: .
Shigematsu T; Department of Gastroenterology, Saiseikai Shiga Prefectural Hospital, 2-4-1, Ohashi Ritto, 520-3046 Japan. Electronic address: .
Yoshikawa T; Department of Gastric Surgery, The National Hospital Organization National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045 Japan. Electronic address: .
Ishiguro T; Department of Digestive Tract and General Surgery, Saitama Medical Center,1981, Kamoda, Kawagoe, 350-0844 Japan. Electronic address: .
Nakamura M; Comprehensive Cancer Center, Aizawa Hospital, 2-5-1, Honjo, Matsumoto, 390-0814 Japan. Electronic address: .
Hasegawa H; Department of Gastroenterology, National Hospital Organization Osaka National Hospital, 2-1-14, Houenzaka, Chuo-ku, Osaka, 540-0006 Japan. Electronic address: .
Morita S; Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, 54, Shogoinkawaharacho, Sakyo-ku, Kyoto, 606-8397 Japan. Electronic address: .
Miyashita Y; Data Center, Epidemiological & Clinical Research Information Network, 21-7, Shogoinsannocho, Sakyo-ku, Kyoto, 606-8392 Japan. Electronic address: .
Tsuburaya A; Department of Surgery, Ozawa Hospital, 1-1-17, Honcho, Odawara, 250-0012 Japan. Electronic address: .
Sakamoto J; Tokai Central Hospital, 4-6-2, Sohara Higashijimacho, Kakamigahara, 504-8601 Japan. Electronic address: .
Tsujinaka T; Kaizuka City Hospital, 3-10-20, Hori, Kaizuka, 597-0015 Japan. Electronic address: .
Pokaż więcej
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2020 Jun; Vol. 132, pp. 159-167. Date of Electronic Publication: 2020 May 05.
Typ publikacji :
Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Chemotherapy, Adjuvant/*mortality
Neoplasm Recurrence, Local/*pathology
Stomach Neoplasms/*pathology
Adult ; Aged ; Aged, 80 and over ; Cisplatin/administration & dosage ; Female ; Follow-Up Studies ; Humans ; Irinotecan/administration & dosage ; Male ; Middle Aged ; Neoplasm Recurrence, Local/drug therapy ; Prognosis ; Stomach Neoplasms/drug therapy ; Survival Rate
Czasopismo naukowe
Tytuł :
A study of second-line irinotecan plus cisplatin vs. irinotecan alone in platinum-naïve patients with early relapse of gastric cancer refractory to adjuvant S-1 monotherapy: exploratory subgroup analysis of the randomized phase III TRICS trial.
Autorzy :
Nishikawa K; Department of Surgery, National Hospital Organization Osaka National Hospital, 2-1-14, Houenzaka, Chuo-ku, Osaka, 540-0006, Japan. .
Murotani K; Biostatistics Center, Graduate School of Medicine, Kurume University, 67 Asahi-Machi, Kurume, Fukuoka, 830-0011, Japan.
Fujitani K; Department of Surgery, Osaka General Medical Center, 3-1-56, Bandaihigashi, Sumiyoshi-ku, Osaka, 558-0056, Japan.
Inagaki H; Department of Surgery, Inagaki Clinic, 1-2-9, Nenohanacho, Owariasahi, 488-0002, Japan.
Akamaru Y; Department of Surgery, Ikeda Municipal Hospital, 3-1-18 Jonan, Ikeda, 563-8510, Japan.
Tokunaga S; Department of Medical Oncology, Osaka City General Hospital, 2-13-22, Miyakojimahondori, Miyakojima-ku, Osaka, 534-0021, Japan.
Takagi M; Department of Surgery, Shizuoka General Hospital, 4-27-1, Kitaando, Aoi-ku, Shizuoka, 420-0881, Japan.
Tamura S; Department of Surgery, Yao Municipal Hospital, 1-3-1, Ryugecho, Yao, 581-0069, Japan.
Sugimoto N; Department of Medical Oncology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-ku, Osaka, 541-8567, Japan.
Shigematsu T; Department of Gastroenterology, Saiseikai Shiga Prefectural Hospital, 2-4-1, Ohashi, Ritto, 520-3046, Japan.
Yoshikawa T; Department of Gastric Surgery, The National Hospital Organization National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Ishiguro T; Department of Digestive Tract and General Surgery, Saitama Medical Center, 1981 Kamoda, Kawagoe, 350-0844, Japan.
Nakamura M; Comprehensive Cancer Center, Aizawa Hospital, 2-5-1, Honjo, Matsumoto, 390-0814, Japan.
Hasegawa H; Department of Gastroenterology, National Hospital Organization Osaka National Hospital, 2-1-14, Houenzaka, Chuo-ku, Osaka, 540-0006, Japan.
Morita S; Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, 54, Shogoinkawaharacho, Sakyo-ku, Kyoto, 606-8397, Japan.
Miyashita Y; Data Center, Epidemiological and Clinical Research Information Network, 21-7, Shogoinsannocho, Sakyo-ku, Kyoto, 606-8392, Japan.
Tsuburaya A; Department of Surgery, Ozawa Hospital, 1-1-17, Honcho, Odawara, 250-0012, Japan.
Sakamoto J; Tokai Central Hospital, 4-6-2, Higashijimacho Sohara, Kakamigahara, 504-8601, Japan.
Tsujinaka T; Kaizuka City Hospital, 3-10-20, Hori, Kaizuka, 597-0015, Japan.
Pokaż więcej
Źródło :
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2019 May; Vol. 83 (5), pp. 867-874. Date of Electronic Publication: 2019 Feb 26.
Typ publikacji :
Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Stomach Neoplasms/*drug therapy
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cisplatin/administration & dosage ; Drug Combinations ; Female ; Humans ; Irinotecan/administration & dosage ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Oxonic Acid/administration & dosage ; Progression-Free Survival ; Survival Rate ; Tegafur/administration & dosage ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Prognostic Significance of Conversion Surgery Following First- or Second-line Chemotherapy for Unresectable Gastric Cancer.
Autorzy :
Fukuchi M; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan .
Mochiki E; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Ishiguro T; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Kumagai Y; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Ishibashi K; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Ishida H; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2018 Nov; Vol. 38 (11), pp. 6473-6478.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Stomach Neoplasms/*drug therapy
Stomach Neoplasms/*surgery
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neoplasm Staging ; Odds Ratio ; Prognosis ; Retrospective Studies ; Stomach Neoplasms/pathology ; Survival Analysis ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Efficacy of Conversion Surgery Following S-1 plus Cisplatin or Oxaliplatin Chemotherapy for Unresectable Gastric Cancer.
Autorzy :
Fukuchi M; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan .
Mochiki E; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Ishiguro T; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Ogura T; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Sobajima J; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Kumagai Y; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Ishibashi K; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Ishida H; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2017 Mar; Vol. 37 (3), pp. 1343-1347.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Cisplatin/*administration & dosage
Organoplatinum Compounds/*administration & dosage
Oxonic Acid/*administration & dosage
Stomach Neoplasms/*drug therapy
Stomach Neoplasms/*surgery
Tegafur/*administration & dosage
Adult ; Aged ; Aged, 80 and over ; Antimetabolites, Antineoplastic/administration & dosage ; Antineoplastic Agents ; Databases, Factual ; Disease Progression ; Drug Combinations ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Odds Ratio ; Oxaliplatin ; Proportional Hazards Models ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
[A Case of Familial Adenomatous Polyposis with a Desmoid Tumor Probably Communicating to the Intestinal Lumen That Was Successfully Treated with Non-Surgical Therapy].
Autorzy :
Ito T; Dept. of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University.
Chika N
Yamamoto A
Ogura T
Amano K
Ishiguro T
Fukuchi M
Kumagai Y
Ishibashi K
Eguchi H
Okazaki Y
Mochiki E
Ishida H
Pokaż więcej
Źródło :
Gan to kagaku ryoho. Cancer & chemotherapy [Gan To Kagaku Ryoho] 2016 Nov; Vol. 43 (12), pp. 2316-2319.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Adenomatous Polyposis Coli/*drug therapy
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Fibromatosis, Aggressive/*drug therapy
Adenomatous Polyposis Coli/genetics ; Adenomatous Polyposis Coli/therapy ; Adenomatous Polyposis Coli Protein/genetics ; Adult ; Dacarbazine/administration & dosage ; Doxorubicin/administration & dosage ; Drainage ; Fibromatosis, Aggressive/genetics ; Fibromatosis, Aggressive/therapy ; Frameshift Mutation ; Humans ; Male ; Pedigree
Czasopismo naukowe
Tytuł :
[A Case of Advanced Gastric Cancer Successfully Treated with Curative Conversion Surgery after Chemotherapy with S-1 plus Oxaliplatin].
Autorzy :
Ishiguro T; Dept. of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University.
Fukuchi M
Ogura T
Muta Y
Mochiki E
Ishida H
Pokaż więcej
Źródło :
Gan to kagaku ryoho. Cancer & chemotherapy [Gan To Kagaku Ryoho] 2016 Nov; Vol. 43 (12), pp. 2213-2215.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Peritoneal Neoplasms/*drug therapy
Stomach Neoplasms/*drug therapy
Aged, 80 and over ; Drug Combinations ; Humans ; Male ; Organoplatinum Compounds/administration & dosage ; Oxaliplatin ; Oxonic Acid/administration & dosage ; Peritoneal Neoplasms/secondary ; Stomach Neoplasms/blood supply ; Stomach Neoplasms/complications ; Stomach Neoplasms/surgery ; Tegafur/administration & dosage ; Thrombosis/etiology
Czasopismo naukowe
Tytuł :
Improved Efficacy by Addition of Protein-bound Polysaccharide K to Adjuvant Chemotherapy for Advanced Gastric Cancer.
Autorzy :
Fukuchi M; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan .
Mochiki E; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Ishiguro T; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Ogura T; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Sobajima J; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Kumagai Y; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Ishibashi K; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Ishida H; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2016 Aug; Vol. 36 (8), pp. 4237-41.
Typ publikacji :
Journal Article
MeSH Terms :
Chemotherapy, Adjuvant*
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Fungal Proteins/*administration & dosage
Polysaccharides/*administration & dosage
Stomach Neoplasms/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Disease-Free Survival ; Drug Combinations ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Oxonic Acid/administration & dosage ; Postoperative Period ; Stomach Neoplasms/pathology ; Stomach Neoplasms/surgery ; Tegafur/administration & dosage
Czasopismo naukowe
Tytuł :
[Efficacy of Postoperative Chemotherapy in Stage Ⅳ Colorectal Cancer with Perforation].
Autorzy :
Onozawa H; Dept. of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University.
Kumamoto K
Matsuzawa T
Ishiguro T
Sobajima J
Fukuchi M
Kumagai Y
Ishibashi K
Mochiki E
Ishida H
Pokaż więcej
Źródło :
Gan to kagaku ryoho. Cancer & chemotherapy [Gan To Kagaku Ryoho] 2015 Nov; Vol. 42 (12), pp. 2242-4.
Typ publikacji :
English Abstract; Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*adverse effects
Colorectal Neoplasms/*drug therapy
Intestinal Perforation/*chemically induced
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Chemotherapy, Adjuvant ; Colectomy ; Colorectal Neoplasms/pathology ; Colorectal Neoplasms/surgery ; Female ; Humans ; Intestinal Perforation/surgery ; Male ; Middle Aged ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer.
Autorzy :
Fukuchi M; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan. .
Ishiguro T; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Ogata K; Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan.
Suzuki O; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Kumagai Y; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Ishibashi K; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Ishida H; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Kuwano H; Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan.
Mochiki E; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Pokaż więcej
Źródło :
Annals of surgical oncology [Ann Surg Oncol] 2015 Oct; Vol. 22 (11), pp. 3618-24. Date of Electronic Publication: 2015 Feb 07.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma/*pathology
Adenocarcinoma/*therapy
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Stomach Neoplasms/*pathology
Stomach Neoplasms/*therapy
Adult ; Aged ; Chemotherapy, Adjuvant ; Cisplatin/administration & dosage ; Disease-Free Survival ; Drug Combinations ; Female ; Gastrectomy ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neoadjuvant Therapy ; Neoplasm Grading ; Neoplasm Staging ; Neoplasm, Residual ; Oxonic Acid/administration & dosage ; Paclitaxel/administration & dosage ; Proportional Hazards Models ; Retrospective Studies ; Survival Rate ; Tegafur/administration & dosage
Czasopismo naukowe
Tytuł :
Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trial.
Autorzy :
Nishikawa K; Department of Surgery, Osaka National Hospital, 2-1-14, Houenzaka, Chuo-ku, Osaka 540-0006, Japan. Electronic address: .
Fujitani K; Department of Surgery, Osaka General Medical Center, 3-1-56, Bandaihigashi, Sumiyoshi-ku, Osaka 558-0056, Japan. Electronic address: .
Inagaki H; Department of Surgery, Gifu Central Hospital, 3-25, Kawabe, Gifu 501-1151, Japan. Electronic address: .
Akamaru Y; Department of Surgery, Osaka Kose-Nenkin Hospital, 4-2-78, Fukushima, Fukushima-ku, Osaka 553-0007, Japan. Electronic address: .
Tokunaga S; Department of Clinical Oncology, Osaka City General Hospital, 2-13-22, Miyakojimahondori, Miyakojima-ku, Osaka 534-0021, Japan. Electronic address: .
Takagi M; Department of Surgery, Shizuoka General Hospital, 4-27-1, Kitaando, Aoi-ku, Shizuoka 420-0881, Japan. Electronic address: .
Tamura S; Department of Surgery, Kansai Rosai Hospital, 3-1-69, Inabaso, Amagasaki 537-0025, Japan. Electronic address: .
Sugimoto N; Department of Clinical Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3, Nakamichi, Higashinari-ku, Osaka 537-0025, Japan. Electronic address: .
Shigematsu T; Department of Gastroenterology, Saiseikai Shiga Prefectural Hospital, 2-4-1, Ohashi, Ritto 520-3046, Japan. Electronic address: .
Yoshikawa T; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama 241-0815, Japan. Electronic address: .
Ishiguro T; Department of Digestive Tract and General Surgery, Saitama Medical Center, 1981, Kamoda, Kawagoe 350-0844, Japan. Electronic address: .
Nakamura M; Comprehensive Cancer Center, Aizawa Hospital, 2-5-1, Honjo, Matsumoto 390-0814, Japan. Electronic address: .
Morita S; Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, 54, Shogoinkawaharacho, Sakyo-ku, Kyoto 606-8397, Japan. Electronic address: .
Miyashita Y; Date Center, Epidemiological & Clinical Research Information Network, 21-7, Shogoinsannocho, Sakyo-ku, Kyoto 606-8392, Japan. Electronic address: .
Tsuburaya A; Department of Gastroenterological Center, Yokohama City University Medical Center, 4-57, Urafunecho, Minami-ku, Yokohama 232-0024, Japan. Electronic address: .
Sakamoto J; Tokai Central Hospital, 4-6-2, Higashijimacho Sohara, Kakamigahara 504-8601, Japan. Electronic address: .
Tsujinaka T; Kaizuka City Hospital, 3-10-20, Hori, Kaizuka 597-0015, Japan. Electronic address: .
Pokaż więcej
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2015 May; Vol. 51 (7), pp. 808-16. Date of Electronic Publication: 2015 Mar 18.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Adenocarcinoma/*drug therapy
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Camptothecin/*analogs & derivatives
Cisplatin/*administration & dosage
Oxonic Acid/*therapeutic use
Stomach Neoplasms/*drug therapy
Tegafur/*therapeutic use
Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Adult ; Aged ; Aged, 80 and over ; Camptothecin/administration & dosage ; Camptothecin/adverse effects ; Chemotherapy, Adjuvant ; Cisplatin/adverse effects ; Disease Progression ; Drug Combinations ; Drug Resistance, Neoplasm/drug effects ; Female ; Humans ; Irinotecan ; Male ; Middle Aged ; Stomach Neoplasms/mortality ; Stomach Neoplasms/pathology ; Treatment Failure
Czasopismo naukowe
Tytuł :
[Evaluation of immunity in elderly patients with unresectable gastric cancer receiving S-1/Lentinan combination chemotherapy].
Autorzy :
Fukuchi M; Dept. of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University.
Mochiki E
Ishiguro T
Tsuji Y
Suzuki O
Sobajima J
Baba H
Kumagai Y
Ishibashi K
Ishida H
Pokaż więcej
Źródło :
Gan to kagaku ryoho. Cancer & chemotherapy [Gan To Kagaku Ryoho] 2014 Oct; Vol. 41 (10), pp. 1264-6.
Typ publikacji :
English Abstract; Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Stomach Neoplasms/*drug therapy
Aged ; Aged, 80 and over ; Complement C3/immunology ; Dinoprostone/immunology ; Drug Combinations ; Female ; Humans ; Lentinan/administration & dosage ; Male ; Oxonic Acid/administration & dosage ; Prognosis ; Stomach Neoplasms/immunology ; Stomach Neoplasms/pathology ; T-Lymphocytes, Regulatory/immunology ; Tegafur/administration & dosage
Czasopismo naukowe
Tytuł :
Prognostic factors for stage IV gastric cancer.
Autorzy :
Baba H; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Kuwabara K
Ishiguro T
Kumamoto K
Kumagai Y
Ishibashi K
Haga N
Ishida H
Pokaż więcej
Źródło :
International surgery [Int Surg] 2013 Apr-Jun; Vol. 98 (2), pp. 181-7.
Typ publikacji :
Evaluation Study; Journal Article
MeSH Terms :
Gastrectomy*
Adenocarcinoma/*therapy
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Stomach Neoplasms/*therapy
Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/administration & dosage ; Chemotherapy, Adjuvant ; Drug Combinations ; Female ; Humans ; Male ; Middle Aged ; Neoadjuvant Therapy ; Neoplasm Staging ; Oxonic Acid/therapeutic use ; Prognosis ; Pyridines/therapeutic use ; Retrospective Studies ; Stomach Neoplasms/mortality ; Stomach Neoplasms/pathology ; Survival Analysis ; Tegafur/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł :
A favorable response to cisplatin, pemetrexed and bevacizumab in two cases of invasive mucinous adenocarcinoma formerly known as pneumonic-type mucinous bronchioloalveolar carcinoma.
Autorzy :
Yamakawa H; Department of Respiratory Medicine, Saitama Cardiovascular and Respiratory Center, Japan.
Takayanagi N
Ishiguro T
Kagiyama N
Shimizu Y
Sugita Y
Pokaż więcej
Źródło :
Internal medicine (Tokyo, Japan) [Intern Med] 2013; Vol. 52 (24), pp. 2781-4.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Adenocarcinoma, Bronchiolo-Alveolar/*drug therapy
Adenocarcinoma, Mucinous/*drug therapy
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Lung Neoplasms/*drug therapy
Adenocarcinoma, Bronchiolo-Alveolar/diagnosis ; Adenocarcinoma, Bronchiolo-Alveolar/pathology ; Adenocarcinoma, Mucinous/diagnosis ; Adenocarcinoma, Mucinous/pathology ; Aged ; Antibodies, Monoclonal, Humanized/administration & dosage ; Bevacizumab ; Cisplatin/administration & dosage ; Female ; Glutamates/administration & dosage ; Guanine/administration & dosage ; Guanine/analogs & derivatives ; Humans ; Lung Neoplasms/diagnosis ; Lung Neoplasms/pathology ; Male ; Neoplasm Invasiveness/diagnosis ; Neoplasm Invasiveness/pathology ; Pemetrexed ; Treatment Outcome
Czasopismo naukowe
Tytuł :
[Predictive value of Köhne's index on the efficacy of FOLFIRI regimen in the treatment of unresectable liver metastatsis of colorectal cancer].
Autorzy :
Ishibashi K; Dept. of Digestive Tract and General Surgery, Saitama Medical University, Japan.
Okada N
Tajima Y
Amano K
Hatano S
Kuwabara K
Sobajima J
Ishiguro T
Ohsawa T
Kumamoto K
Kumagai Y
Baba H
Tsuji Y
Haga N
Ishida H
Pokaż więcej
Źródło :
Gan to kagaku ryoho. Cancer & chemotherapy [Gan To Kagaku Ryoho] 2012 Nov; Vol. 39 (12), pp. 2182-4.
Typ publikacji :
English Abstract; Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Colorectal Neoplasms/*drug therapy
Liver Neoplasms/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Camptothecin/administration & dosage ; Camptothecin/analogs & derivatives ; Colorectal Neoplasms/pathology ; Female ; Fluorouracil/administration & dosage ; Humans ; Leucovorin/administration & dosage ; Liver Neoplasms/secondary ; Male ; Middle Aged ; Retrospective Studies
SCR Protocol :
IFL protocol
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies